TMED9 and head and neck squamous cell carcinoma: Notably, we observed significantly high TMED9 expression during the M1 stage of head and neck squamous cell carcinoma (HNSC), KIRC, and mesothelioma (MESO), while significantly low expression was evident in the M1 stage of LUAD, suggesting a potential association with tumor metastasis.